Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agilent Technologies Inc. filings document financial reporting and governance matters for an analytical and clinical laboratory technology company. Form 8-K reports include quarterly financial-result releases, Regulation FD disclosures, non-GAAP measure explanations, executive officer transitions, compensatory arrangements and amendments to charter and bylaws.
Proxy and annual-meeting filings cover director elections, stockholder voting, executive compensation, equity awards and the phased declassification of the board. The records also identify governance changes tied to the company’s Delaware certificate of incorporation and bylaws, together with furnished press releases and related exhibits.
Agilent Technologies (A) reported an insider equity transaction by its Senior Vice President. On 11/21/2025, the executive surrendered 113 shares of common stock at a price of $151.25 per share to Agilent Technologies, Inc. to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. After this tax-related share surrender, the reporting person beneficially owned 14,692 shares of Agilent common stock, held directly.
Agilent Technologies (ticker: A) officer reports routine tax share surrender. On 11/21/2025, the company’s V.P., Corporate Controller reported a Form 4 transaction coded “F,” meaning 138 shares of common stock were surrendered to Agilent Technologies, Inc. to cover taxes due on the vesting of restricted stock units. After this transaction, the reporting person beneficially owned 34,845.6872 shares of Agilent common stock directly and 40.192 shares indirectly through the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees. This filing records an administrative tax-withholding event rather than an open-market trade.
Agilent Technologies, Inc. filed a Form 8-K to announce that it has released financial results for its fourth fiscal quarter ended October 31, 2025, via a press release furnished as Exhibit 99.1. The company highlights that this press release includes both GAAP and non-GAAP financial measures that management uses to evaluate segment and enterprise performance and to compare results with prior periods and competitors.
Agilent explains that its non-GAAP information excludes items such as restructuring and amortization and is intended to give investors additional insight into operational performance, while not serving as a substitute for U.S. GAAP. The company notes it has historically provided similar non-GAAP metrics and that further explanation of these measures is included in Exhibit 99.1.
Agilent Technologies (A) reported an equity award to a senior executive. A Senior Vice President received 6,922 shares of common stock in the form of restricted stock units on 11/18/2025 at a stated price of $0, reflecting that this is a stock-based compensation grant rather than an open-market purchase. These restricted stock units vest in four equal annual installments beginning on November 18, 2026, meaning the executive earns the shares over time if service conditions are met.
After this award, the executive beneficially owns 12,535.056 shares of Agilent common stock directly. This total includes 137.654 shares acquired through an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code in a transaction exempt under Rule 16b-3. The filing is made on Form 4 by a single reporting person in the capacity of officer.
Agilent Technologies, Inc. (A) reported insider equity activity for a Senior Vice President on a Form 4. On November 18, 2025, the executive received 1,421 shares of common stock at $0 under the Long-Term Performance Program, with a one-year holding requirement after vesting. On the same date, the executive surrendered 452 shares back to Agilent at $143.84 to cover taxes on vested restricted stock units. The executive was also granted 5,227 restricted stock units at $0 under the 2018 Stock Plan, which vest in four equal annual installments beginning on November 18, 2026. Following these transactions, the executive directly beneficially owned 11,914.0318 shares of Agilent common stock.
Agilent Technologies (A) reported insider equity awards and tax withholding for a senior vice president. On November 18, 2025, the executive received 1,493 shares of common stock under Agilent’s Long-Term Performance Program, which are subject to a one-year post-vest holding period. The executive also surrendered 489 shares back to Agilent at a price of $143.84 per share to cover taxes on vesting restricted stock units.
In addition, the executive was granted 6,781 restricted stock units under the 2018 Stock Plan, which vest in four equal annual installments beginning on November 18, 2026. Following these transactions, the executive beneficially owned 26,948.9266 shares directly, with an additional 2,607.6856 shares held indirectly through a spouse.
Agilent Technologies (A) president and CEO Michael McMullen reported several equity transactions on November 18, 2025. He sold 911 shares of common stock at $143.24 per share under a pre-arranged Rule 10b5-1 trading plan. On the same date, he received 7,104 shares of common stock issued under Agilent’s Long-Term Performance Program, which carry a 1-year post-vest holding period.
To cover taxes on vesting restricted stock units, he surrendered 3,474 shares back to Agilent at $143.84 per share. He was also granted 33,340 restricted stock units under the 2018 Stock Plan, vesting in four equal annual installments beginning November 18, 2026. After these transactions, he directly beneficially owned 69,028 shares of Agilent common stock.
Agilent Technologies (A) reported an equity grant to a senior executive. A Senior Vice President received 6,781 shares of common stock in the form of restricted stock units on 11/18/2025 at a stated price of $0, reflecting that this is an award rather than a market purchase.
The restricted stock units were granted under the Agilent Technologies, Inc. 2018 Stock Plan and will vest in four equal annual installments beginning on November 18, 2026. Following this grant, the reporting person beneficially owns 14,507.2469 shares of Agilent common stock, which includes 234.83 shares acquired through an Employee Stock Purchase Plan transaction that is exempt under Rule 16b-3.
Agilent Technologies (A) reported insider equity activity for a Senior Vice President on Form 4. On November 18, 2025, the executive received 1,438 shares of common stock at $0 under the company’s Long-Term Performance Program, with a 1-year post-vest holding period.
On the same date, the executive surrendered 772 shares at $143.84 to cover taxes on vested restricted stock units. The executive was also granted 6,075 restricted stock units under the 2018 Stock Plan, which vest in four equal annual installments starting on November 18, 2026. After these transactions, the executive directly owned 14,805 shares of Agilent common stock.
Agilent Technologies (ticker A) reported insider equity activity for its Vice President and Corporate Controller, Rodney Gonsalves. On November 18, 2025, he received 2,540 shares of common stock under Agilent’s Long-Term Performance Program, which are subject to a one-year holding period after vesting. On the same date, he surrendered 883 shares back to Agilent to cover tax liabilities related to vesting restricted stock units.
He also received 2,402 restricted stock units under the Agilent 2018 Stock Plan, which are scheduled to vest in four equal annual installments beginning November 18, 2026. Following these transactions, he beneficially owned 34,983.6872 shares directly, plus 40.192 shares held indirectly through the Gonsalves Trust, for which he and Rochelle Gonsalves serve as trustees.